LABGROUP

Meet Our Scientific Team

Donato Inverso

Professor of Pathology and Head of the Vascular Pathobiology Unit | ERC Consolidator Grant Awardee.

Donato Inverso is Head of the Vascular Pathobiology Unit at the San Raffaele Scientific Institute (Milan, Italy) and Professor of Pathology at Università Vita-Salute San Raffaele. His research focuses on understanding how the vasculature regulates liver homeostasis and disease, with particular emphasis on liver zonation, chronic liver inflammation, metabolic liver disease, and hepatocellular carcinoma.

Following his PhD training in Basic and Applied Immunology at Università Vita-Salute San Raffaele and postdoctoral studies at the German Cancer Research Center (DKFZ, Heidelberg), he established an internationally recognized research program at the interface of vascular biology, immunology, and liver pathobiology. His work has contributed to the discovery of fundamental mechanisms regulating liver immune surveillance, endothelial specialization, and vascular control of chronic liver diseases.

His research is currently supported by an ERC Consolidator Grant, an AIRC Start-Up Grant, and European collaborative funding programs.

Donato Inverso is Head of the Vascular Pathobiology Unit at the San Raffaele Scientific Institute and Professor of Pathology at Università Vita-Salute San Raffaele (Milan, Italy). His research focuses on understanding how vascular specialization regulates liver homeostasis and disease, with particular emphasis on liver zonation, chronic liver inflammation, metabolic liver disease, and hepatocellular carcinoma.

Donato was originally trained as a pathologist at the Faculty of Veterinary Medicine (Naples, Italy) and obtained his PhD in Basic and Applied Immunology at Università Vita-Salute San Raffaele in 2015. During his doctoral training, he investigated the mechanisms of immune surveillance in the liver and developed innovative correlative microscopy approaches that allowed the visualization of immune cell interactions within the hepatic microenvironment. These studies led to the identification of a previously unrecognized mechanism by which intravascular T cells directly survey hepatocytes through endothelial fenestrations.

In 2016, he joined the laboratory of Prof. Hellmut G. Augustin at the German Cancer Research Center (DKFZ, Heidelberg), where he worked at the interface of vascular biology and liver pathobiology. Supported by EMBO and DKFZ fellowships, he developed novel approaches to study endothelial heterogeneity and signaling across the liver lobule, contributing to the generation of the first spatially resolved phosphoproteomic map of a vascular bed. During this period, he also collaborated extensively with investigators in the fields of chronic liver inflammation and cancer, contributing to studies that uncovered key immune mechanisms driving NASH progression and hepatocellular carcinoma development.

In 2022, he established the Vascular Pathobiology Unit at the San Raffaele Scientific Institute. His current research aims to understand how endothelial cells actively regulate liver physiology and pathology through spatially organized signaling programs. By integrating vascular biology, pathology, immunology, and spatial multi-omics technologies, his laboratory investigates how alterations in endothelial signaling contribute to chronic hepatitis, MASLD/MASH progression, liver regeneration, and liver cancer.

In 2023, he was awarded an ERC Consolidator Grant to investigate the vascular control of chronic liver disease progression. Together with support from an AIRC Start-Up Grant and European collaborative research programs, this work is establishing new experimental frameworks to understand how vascular dysfunction contributes to liver pathology and to identify novel therapeutic opportunities targeting the liver vasculature.

Michele D’Antonio

Research Fellow

Michele D’Antonio obtained his master degree in Veterinary Medicine in 2022, he joined Inverso Lab as research fellow in 2022, and his research centers on elucidating the role of endothelial cells in chronic liver diseases.

Michele D’Antonio obtained his master degree in Veterinary Medicine in 2022. Michele have a well-established expertise in mouse pathology and histopathology, and on murine model of dietary induced metabolic dysfunction. He joined Inverso Lab as research fellow in 2022, and his research centers on elucidating the role of endothelial cells in chronic liver diseases, including NASH, HCC, and HBV infection.

Chiara Perucchini

Technician

Chiara Perucchini is a Technician specializing in the development and management of sophisticated mouse models for immunological and hepatological studies.

Chiara Perucchini graduated in 2014 with a degree in Biology and Nutritional Sciences from the University of Milan. Over the past 10 years, she has worked in experimental immunology and liver pathobiology, acquiring strong expertise in various in vivo models for infectious diseases (such as HBV and SARS-CoV-2) and tumor immunology. Since 2022, she has been a Technician at Inverso Lab, shared with Iannacone Lab. Her current focus is on developing different murine models for steatohepatitis, liver regeneration, and HBV infection.

Davide Marotta

Post-Doctoral fellow

Davide joined the Inverso Lab in 2024, working on a project related to the role of the adaptive immune response in hepatocellular carcinoma and non-alcoholic steatohepatitis.

Davide obtained his PhD in 2023 at the Unit of the Dynamics of Immune Responses (San Raffaele University, Milan), working on a project aimed at investigating the role of the adaptive immune response during SARS-CoV-2 infection. He has strong expertise in immune phenotyping and multispectral flow cytometry in various biological settings, including acute infection and sterile inflammation. Since 2024, he has been working on a project related to the role of the adaptive immune response in hepatocellular carcinoma and non-alcoholic steatohepatitis.

Natalia Herman, PhD. Spain

Post-Doctoral fellow

Natalia is a Postdoctoral Researcher with expertise in liver biology, molecular oncology, and translational research. In 2026, Natalia joined our Lab to investigate the molecular mechanisms regulating liver zonation and their contribution to chronic liver diseases

Natalia obtained her PhD in Biomedicine in 2026 at the University of Cordoba (Spain). Her doctoral research focused on precision oncology, with the aim of identifying novel diagnostic and therapeutic strategies for liver tumours. In particular, she investigated the cellular mechanisms controlling gene expression, including mRNA splicing and mRNA translation. During her PhD, Natalia developed strong expertise in molecular biology, translational research, and both in vitro and in vivo models of liver disease. She also established an excellent publication record, contributing to more than 15 peer-reviewed articles, including studies published in leading journals in the field. In 2026, Natalia joined our Lab to study the molecular mechanisms underlying liver zonation and their impact on chronic hepatitis.

Madalena Marinho. Portugal

Research Fellow

Madalena is a Research Fellow with a background in cell and molecular biology. In 2026, she joined the Vascular Pathobiology Unit to investigate how immune responses shape tissue organization and chronic inflammation in the liver.

Madalena Marinho obtained her Master’s degree in Biomedical Research after completing a Bachelor’s degree in Cell and Molecular Biology. During her academic training, she worked on translational research projects in cancer biology and immunology, developing expertise in molecular and cellular biology techniques. In 2026, she joined the Vascular Pathobiology Unit as a Research Fellow, where she investigates how immune responses and immune–endothelial interactions contribute to chronic inflammatory liver diseases.

Mara Caputo, PhD. Italy

Post-Doctoral fellow

Mara is a Postdoctoral Researcher studying the vascular control of chronic liver diseases and liver cancer. Her research focuses on understanding how endothelial signaling shapes disease progression and therapeutic responses in MASLD, MASH, and hepatocellular carcinoma.

Mara is a Postdoctoral Researcher in the Vascular Pathobiology Unit, where she investigates how the liver vasculature regulates chronic inflammation, metabolic dysfunction, and cancer development. Her work focuses on the role of endothelial signaling pathways in shaping disease progression across the MASLD–MASH–HCC spectrum, with the goal of identifying novel vascular mechanisms and therapeutic targets. By integrating in vivo models with molecular and cellular approaches, she studies how vascular remodeling influences liver homeostasis, disease evolution, and response to treatment.

Jacqueline Simone Welz. Germany.

Research Fellow

Jacqueline is a Research Fellow with a background in Molecular Medicine. In 2026, she joined Inverso Lab to investigate the molecular mechanisms regulating liver endothelial cell identity and specialization, and their contribution to liver homeostasis and chronic liver diseases.

Jacqueline obtained her master degree in molecular medicine from Goethe University (Frankfurt, Germany) in 2026. She has strong expertise in molecular biology and histology, with additional experience in cloning, viral vector production and murine models of liver disease and colorectal cancer. She joined Inverso Lab as a Research Fellow in 2026, where she investigates the molecular pathways regulating liver endothelial cell identity, specialization, and function. Her research focuses on understanding how endothelial cells contribute to liver homeostasis and how alterations in endothelial programs influence chronic liver disease progression.

Marco Bianchi. Italy.

Research Fellow in Bio

Marco is a Research Fellow with expertise in bioinformatics and computational biology. Since joining the Inverso Lab in 2025, he has been investigating the molecular mechanisms underlying liver zonation and their contribution to chronic liver diseases through the analysis of transcriptomics data.

Marco obtained his Master’s degree in Bioinformatics for Computational Genomics from the University of Milan and Politecnico di Milano in 2024. During his studies and internship, he developed expertise in the analysis of transcriptomics data, including bulk and single-cell RNA sequencing, and cultivated an interest in spatial transcriptomics approaches. In 2025, Marco joined the Inverso Lab as a Research Fellow, where he applies transcriptomics approaches to investigate the molecular mechanisms underlying liver zonation and chronic liver diseases.

Lab Alumni

Monica Giannotta​ 2022 – 2025 | Now Assistant Professor Università Pavia